INOVIQ Ltd - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

London police arrest 139 protesters outside US Embassy over Palestine Action ban

ExxonMobil (XOM) earns $15.4bn as refining profits surge and $20bn buyback plan emerges

Perrigo (PRGO) agrees to sell $380m infant formula business for $40m upfront as impairment looms

Pilgrim’s Pride (PPC) Q3 operating profit falls 61% despite Just Bare sales growth as chicken prices weaken

INOVIQ Ltd (ASX: IIQ) highlights its EXO-OC ovarian cancer screening breakthrough at ASCO 2025, achieving 77% sensitivity and 99.6% specificity.

Read More

Healthcare Industry News

INOVIQ (ASX: IIQ) soars on breakthrough ovarian cancer test data at ASCO 2025

INOVIQ Ltd (ASX: IIQ) stock surged 47.73% after ASCO 2025 data showed 77% sensitivity, 99.6% specificity in ovarian cancer screening. Explore what's next for EXO-OC.

byPallavi Madhiraju

June 2, 2025

web analytics